MEDICAMEQ.NS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 17:59):

Stats
今日成交量	20 462.00
平均成交量	58 424.00
市值	6.85B
EPS	INR0 ( 2024-02-11 )
下一个收益日期	( INR0 ) 2024-05-27
Last Dividend	INR1.000 ( 2022-09-19 )
Next Dividend	INR0 ( N/A )
P/E	59.94
ATR14	INR0.953 (0.17%)

音量相关性

長: 0.09 (neutral)

短: -0.80 (moderate negative)

Signal:(56.37) Neutral

Medicamen Biotech Limited 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Medicamen Biotech Limited 相关性 - 货币/商品

-0.22
( neutral )

-0.62
( weak negative )

0.66
( moderate )

0.37
( neutral )

-0.19
( neutral )

-0.30
( neutral )

Medicamen Biotech Limited 财务报表

Annual	2022
营收:	INR1.41B
毛利润:	INR687.74M (48.82 %)
EPS:	INR11.92

FY	2022
营收:	INR1.41B
毛利润:	INR687.74M (48.82 %)
EPS:	INR11.92

FY	2022
营收:	INR1.15B
毛利润:	INR479.88M (41.57 %)
EPS:	INR12.19

FY	2021
营收:	INR1.13B
毛利润:	INR335.16M (29.74 %)
EPS:	INR9.93

Financial Reports:

No articles found.

Medicamen Biotech Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.000 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Medicamen Biotech Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.57 - low (18.86%) | Divividend Growth Potential Score: 2.46 - Decrease likely (50.72%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2022-09-19
Last Dividend	INR1.000	2022-09-19
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	INR1.000	--
Avg. Dividend % Per Year	0.02%	--
Score	1.43	--
Div. Sustainability Score	3.57
Div.Growth Potential Score	2.46
Div. Directional Score	3.02	--

Next Divdend (Est)
(2024-05-06)

INR0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.43

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2022	INR1.000	0.10%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SYMPHONY.NS	Dividend Knight	2023-08-04	Semi-Annually	14	0.47%
NESCO.NS	Dividend Junior	2023-07-28	Annually	17	0.40%
IDBI.NS	Dividend Junior	2023-07-06	Sporadic	27	0.48%
CERA.NS	Dividend Junior	2023-06-20	Annually	17	0.39%
RVNL.NS	Dividend Knight	2023-09-20	Annually	6	3.08%
LSIL.NS	Dividend Junior	2023-07-17	Annually	3	0.23%
GEOJITFSL.NS	Dividend Knight	2023-06-30	Annually	20	2.79%
ARVIND.NS	Dividend Junior	2023-07-21	Sporadic	20	0.59%
THEMISMED.NS	Dividend Junior	2023-08-31	Sporadic	18	0.39%
ORIENTELEC.NS	Dividend Junior	2023-07-26	Semi-Annually	7	0.41%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0671	1.500	8.66	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0582	1.500	-0.464	-0.696	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	5.27	1.000	9.16	9.16	[3 - 30]
operatingCashFlowPerShareTTM	10.97	2.00	6.34	10.00	[0 - 30]
freeCashFlowPerShareTTM	10.97	2.00	4.51	9.03	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.469	1.000	5.52	5.52	[0.2 - 0.8]
operatingProfitMarginTTM	0.104	1.000	9.92	9.92	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.57

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	58.67	1.000	4.17	0	[1 - 100]
returnOnEquityTTM	0.0582	2.50	-0.298	-0.696	[0.1 - 1.5]
freeCashFlowPerShareTTM	10.97	2.00	6.34	9.03	[0 - 30]
dividendYielPercentageTTM	0.188	1.500	5.29	0	[0 - 0.4]
operatingCashFlowPerShareTTM	10.97	2.00	6.34	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.126	1.500	-4.17	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0814	1.000	-0.466	0	[0.1 - 0.5]
Total Score				2.46

Medicamen Biotech Limited

Medicamen Biotech Limited manufactures and sells pharmaceutical formulations in India. The company offers its products in various forms, including tablets, capsules, liquid and dry syrups, and ointments. It also provides oral rehydration solution, mouth wash, and dental care products. The company was incorporated in 1993 and is based in New Delhi, India.